Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer

NCT00967291 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
21
Enrollment
OTHER
Sponsor class

Stopped lack of activity and G3-4 toxicity at interim analysis

Conditions

Interventions

Sponsor

IRCCS San Raffaele